Dexcom Inc Stock Sales by Top Executives
Dexcom Inc has reported significant stock sales by its top executives. The company’s CEO, Kevin Sayer, sold a substantial number of shares. Other high-ranking officials, including COO Jacob Steven Leach and Chief Legal Officer Michael Jon Brown, also participated in the sales.
The stock sales have raised concerns among investors, who are now evaluating the potential impact on the company’s stock price. The recent warning letter from the FDA has not affected the expected continued sales of Dexcom’s CGM sensors.
Key Executives Involved in Stock Sales
- CEO: Kevin Sayer
- COO: Jacob Steven Leach
- Chief Legal Officer: Michael Jon Brown
Company Performance and Stock Price
Dexcom’s stock price has been affected by the recent stock sales. Investors are considering the potential risks and benefits of investing in the company. The expected continued sales of Dexcom’s CGM sensors have not been impacted by the warning letter from the FDA.
Investor Reaction
Investors are evaluating the potential impact of the stock sales on the company’s stock price. Some investors are considering selling their shares or investing in Dexcom. The company’s performance and future prospects will be closely monitored by investors and analysts.